Bernstein told clients on Wednesday that investors are increasingly concerned about the likelihood that Cintas's proposed acquisition of UniFirst will win regulatory approval, a shift that has widened the price gap between the two companies' shares.
Analyst Connor Cerniglia, who carries a Market Perform rating on Cintas with a $200 price target, reported that market-implied odds that the merger will be approved have declined to about 70% from approximately 85% as of Aug. 25.
Over the same interval, UniFirst shares fell roughly 7% while Cintas slid about 2%. The note states this left the business services company's stock up about 18% since the start of July.
Cerniglia identified two primary factors behind the recent pullback in UniFirst. First, the Federal Trade Commission issued civil investigative demands to third-party participants in the industry as part of its review, and the note described those demands as "expansive." While civil investigative demands are a routine part of merger reviews, the use of the adjective "expansive" was interpreted by market participants as signifying broader-than-typical outreach, and selling activity picked up around the reporting of that detail.
The second factor cited was an independent 160-page industry report prepared by Uniform Bright for submission to regulators. According to Bernstein, skeptics contend the report could provide the FTC, the Department of Justice and state attorneys general with material that strengthens antitrust challenges to the transaction.
Despite the caution implied by market pricing, Cerniglia noted that Cintas's management continues to anticipate closing the deal. The firm is scheduled to complete its response to the FTC's second request between September and November, according to the note.
Bernstein reiterated that regulatory approval remains its base case, but emphasized that the market now appears to be assigning roughly a 30% probability to failure - a level the analyst described as "a risk worth monitoring." The firm also said it views the merger as constructive for Cintas over the long term and expects a likely closing in early 2027.
Context and market reaction
The combination of an "expansive" regulatory inquiry and the independent Uniform Bright report coincided with a period of underperformance for UniFirst relative to Cintas. Bernstein's assessment links these developments to a re-pricing of deal odds by investors, even as company management maintains confidence in the transaction timeline.
What remains clear from the note: market-implied approval odds have fallen to about 70%; the FTC's outreach was described as "expansive"; an independent 160-page industry report is part of the regulatory record; Cintas plans to finish its response to the second request between September and November; Bernstein still regards approval as the base case but notes a roughly 30% chance of failure.